Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hanxin Lin

4PUBLICATIONS
5CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer cell biologyCancer diagnosisEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Oct 27, 2022
Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.

Pratibha Bhai, Benjamin Chin-Yee, Victor Pope

|Oct 26, 2021
Cell Entry of Animal Coronaviruses.

Yang-Ran Cheng, Xinglin Li, Xuesen Zhao

|Jul 20, 2021
Incidental findings from cancer next generation sequencing panels.

Nika Maani, Karen Panabaker, Jeanna M McCuaig

|Jul 04, 2019
Genome-wide DNA methylation and RNA analyses enable reclassification of two variants of uncertain significance in a patient with clinical Kabuki syndrome.

Erfan Aref-Eshghi, Danielle K Bourque, Jennifer Kerkhof

Pageof 1

Frequent Collaborators

1 joint publications

Kirsten M Farncombe

1 joint publications

Raymond H Kim

1 joint publications

Xuesen Zhao

1 joint publications

Alan Stuart

1 joint publications

Cyrus C Hsia

Frequent Collaborators

1 joint publications

Kirsten M Farncombe

1 joint publications

Raymond H Kim

1 joint publications

Xuesen Zhao

1 joint publications

Alan Stuart

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

24.5K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.3K
See more related videos

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

24.5K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.3K
See more related videos